Community-acquired pneumonia due to Legionella pneumophila, the utility of PCR, and a review of the antibiotics used

International Journal of General Medicine

Volumn 4, Issue , 2011, Pages 15-19

  Zarogoulidis, Paul ^a,b   Alexandropoulou, Ioanna ^a,b   Romanidou, Gioulia ^c   Konstasntinidis, Theocharis G ^a,b   Terzi, Eirini ^c   Saridou, S ^a   Stefanis, Athanasios ^a   Zarogoulidis, Kostas ^a,b   Constantinidis, T C ^a,b  

^a Regional Laboratory of Public Health   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c Department of Internal Medicine   (Greece)

Author keywords

Legionnaires' disease; Lionella pneumophila

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; CLAVULANIC ACID; CREATININE; LEVOFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; EARLY INTERVENTION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HYPOXEMIA; LABORATORY TEST; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG AUSCULTATION; LUNG INFILTRATE; NONHUMAN; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PNEUMONIA SEVERITY INDEX; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; URINALYSIS;

EID: 84897367207     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S15654     Document Type: Article

References (32)

1. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506-526.
2. Garcia-Vidal C, Carrala J, Fernandes-Sabe N, et al. Aetiology of and risk factors for recurrent community-acquired pneumonia. Clin Microbiol Infect. 2009;15(11):1033-1038.
3. Kohno S. Pontiac fever: non-pneumonic form of legionellosis. Intern Med. 1998;7(12):1003-1004.
4. Bram MWD, Kluytmans JAJW, van den Broucke-Grauls CM, Peters MF. Utility of real-time PCR for diagnosis of Legionnaires' disease in routine clinical practice. J Clin Microbiol. 2008;46:671-677.
5. Lee WL, Slutsky AS. In: Mason, Murray and Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia, PA: Saunders, Elsevier; 2005.
6. Anevlavis S, Petroglou N, Tzavaras A, et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect. 2009; 59(2):83-89.
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low- risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336:243-250.
8. Ortega-Deballon P, Radais F, Facy O, et al. C-Reactive protein is an early predictor of septic complications after elective colorectal surgery. World J Surg. 2010;34(4):808-814.
9. George EL, Panos A. Does a high WBC count signal infection? Nursing. 2005;35(1):20-21.
10. Joseph CA; for the European Working Group for Legionella Infections. Legionnaires' disease in Europe 2000-2002. Epidemiol Infect. 2004; 132:417-424.
11. Alvarez J, Oyaga N, Escofet A, Codony F, Orcau A, Maria Oliva J. Community-acquired legionellosis in the Barcelona region between 1992 and 1999: epidemiological characteristics and diagnostic methods. Med Clin (Barc). 2001;117:495-496.
12. Den Boer JW, Yzerman EP. Diagnosis of Legionella infection in Legionnaires' disease. Eur J Clin Microbiol Infect Dis. 2004;23: 871-878.
13. Gupta SK, Sarosi GA. The role of atypical pathogens in communityacquired pneumonia. Med Clin North Am. 2001;85:1349-1365.
14. Sopena N, Sabria M, Pedro-Botet ML, et al. Prospective study of community- acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis. 1999;18:852-858.
15. Alvarez J, Dominguez A, Sabria M, et al; and the Working group of communicable diseases of the RCESP. Community outbreaks of legionellosis in Catalonia, 1990-2003 [abstract 1324]. Abstracts of the 15th European Congress of Clinical Microbiology and Infectious Diseases (Copenhaguen, Denmark). European Society of Clinical Microbiology and Infectious Diseases. 2005;11Suppl 2: 424s.
16. Benin AL, Benson RF, Besser RE. Trends in Legionnaires' disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis. 2002;35:1039-1046.
17. Formica N, Yates M, Beers M, et al. The impact of diagnosis by Legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease. Epidemiol Infect. 2001;127:275-280.
18. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med. 1994;154:2417-2422.
19. Straus WL, Plouffe JF, File TM Jr, et al. Risk factors for domestic acquisition of legionnaires' disease. Ohio Legionnaires' Disease Group. Arch Intern Med. 1996;156:1685-1692.
20. Garcia-Fulgueiras A, Navarro C, Fenoll D, et al. Legionnaires' disease outbreak in Murcia, Spain. Emerg Infect Dis. 2003;9: 915-921.
21. Greig JE, Carnie JA, Tallis GF, et al. An outbreak of Legionnaires' disease at the Melbourne Aquarium, April 2000: investigation and case-control studies. Med J Aust. 2004;180:566-572.
22. Den Boer JW, Yzerman EP, Schellekens J, et al. A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis. 2002;8:37-43.
23. Mavridou A, Smeti E, Mandilara G, et al. Prevalence study of Legionella spp. contamination in Greek hospitals. Int J Environ Health Res. 2008; 18(4):295-304.
24. Sopena N, Force L, Pedro-Botet ML, et al. Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J. 2007;29:138-142.
25. Pedro-Botet ML, Sabria Leal M, Haro M, et al. Nosocomial and community- aquired Legionella pneumonia:clinical comparative analysis. Eur Respir J. 1995;8:1929-1933.
26. Welti M, Jaton K, Altwegg M, Sahli R, Wenger A, Bille J. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis. 2003; 45(2):85-95.
27. Ginevra C, Barranger C, Ros A, et al. Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR. J Clin Microbiol. 2005;43(7):3247-3254.
28. Pedro-Botet L, Yu VL. Legionella: macrolides or quinolones? Clin Microbiol Infect. 2006;12(Suppl 3):25-30.
29. Sabria M, Pedro-Botet ML, Gomez J, et al; Legionnaires Disease Therapy Group. Fluoroquimolones vs macrolides in the treatment of Legionnaires' disease. Chest. 2005;128:1401-1405.
30. Mykietiuk A, Carratala J, Fernandez-Sabe N, et al. Clinical outcomes for hospitilized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40: 794-799.
31. Yu VL, Greenberg RN, Zadeikis N, et al. Levofloxacin efficacy in the treatment of community-aquired legionellosis. Chest. 2004;125: 2135-2139.
32. Grau S, Mateu-de Antonio J, Ribes E, Salvado M, Garces JM, Garau J. Impact of rifampincin to clarithromycin in Legionella pneumophila pneumonia. Intern J Antimicrob Agents. 2006;28:249-252.